Roche to buy up di­ag­nos­tics part­ner TIB Mol­bi­ol; PAQ to part­ner with In­sil­i­co

Roche is buy­ing its long­time part­ner biotech TIB Mol­bi­ol Group, the Swiss drug­mak­er an­nounced Thurs­day.

While the fi­nan­cial de­tails of the arrange­ment were not dis­closed, the two com­pa­nies have col­lab­o­rat­ed for more than 20 years on tests and reagents for pathogens such as SARS, an­thrax, MERS, the nov­el in­fluen­za virus H1N1 swine, and most re­cent­ly, SARS-CoV-2 virus and its vari­ants.

Roche’s pur­chase will ex­pand their di­ag­nos­tic ca­pa­bil­i­ties, as TIB Mol­bi­ol has over 45 CE-IVD as­says and more than 100 re­search use as­says. These in­clude PCR as­says from an­thrax and SARS-C0V1 in 2001 and 2003, re­spec­tive­ly.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.